Lv42
520 积分 2022-02-15 加入
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
23小时前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
1天前
已完结
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
27天前
已完结
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase
1个月前
已完结
Reprogramming site-specific retrotransposon activity to new DNA sites
1个月前
已完结
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
2个月前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
3个月前
已完结
Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook
3个月前
已完结
Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo
3个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
3个月前
已完结
皖公网安备34019202002308
